Cargando…

Smell as a Disease Marker in Multiple Sclerosis

Existing data suggest that people with multiple sclerosis (pwMS) are at an elevated risk for experiencing olfactory impairment. We investigated if smell dysfunction can be used as an MS disease marker. This is a cross-sectional, case–control study. All data were collected prospectively from 171 part...

Descripción completa

Detalles Bibliográficos
Autores principales:	Printza, Athanasia, Boziki, Marina, Valsamidis, Constantinos, Bakirtzis, Christos, Constantinidis, Jannis, Grigoriadis, Nikolaos, Triaridis, Stefanos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457284/ https://www.ncbi.nlm.nih.gov/pubmed/36079145 http://dx.doi.org/10.3390/jcm11175215

Ejemplares similares

The Impact of Olfactory Dysfunction on the Psychological Status and Quality of Life of Patients with Nasal Obstruction and Septal Deviation
por: Valsamidis, Konstantinos, et al.
Publicado: (2020)

Smell and Taste Loss Recovery Time in COVID-19 Patients and Disease Severity
por: Printza, Athanasia, et al.
Publicado: (2021)

The role of self-reported smell and taste disorders in suspected COVID‑19
por: Printza, Athanasia, et al.
Publicado: (2020)

Efficacy of High-Intensity Training in Patients with Moderate to Severe Dysphagia after Glossectomy
por: Pavlidou, Elena, et al.
Publicado: (2023)

Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
por: Chalkias, Ioannis-Nikolaos, et al.
Publicado: (2022)

The Role of Diet and Interventions on Multiple Sclerosis: A Review
por: Stoiloudis, Panagiotis, et al.
Publicado: (2022)

Prevention, Intervention and Care of Neurodegenerative Diseases
por: Bakirtzis, Christos, et al.
Publicado: (2023)

The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
por: Barmpagiannos, Konstantinos, et al.
Publicado: (2023)

COVID-19 Vaccination and Disease Course in People with Multiple Sclerosis in Greece
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Dysphagia Management in Children: Implementation and Perspectives of Flexible Endoscopic Evaluation of Swallowing (FEES)
por: Printza, Athanasia, et al.
Publicado: (2022)

A Greek Validation Study of the Multiple Sclerosis Work Difficulties Questionnaire-23
por: Bakirtzis, Christos, et al.
Publicado: (2021)

Long-Term Efficacy Outcomes of Natalizumab vs. Fingolimod in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis: Real-World Data From a Multiple Sclerosis Reference Center
por: Boziki, Marina, et al.
Publicado: (2021)

The Role of Primary Repair of the Recurrent Laryngeal Nerve during Thyroid/Parathyroid Surgery in Vocal Outcomes—A Systematic Review
por: Papadopoulou, Elisavet, et al.
Publicado: (2023)

Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response
por: Boziki, Marina, et al.
Publicado: (2022)

The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database
por: Bakirtzis, Christos, et al.
Publicado: (2020)

Dysphagia Severity and Management in Patients with COVID-19
por: PRINTZA, ATHANASIA, et al.
Publicado: (2021)

The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians
por: Bakirtzis, Christos, et al.
Publicado: (2018)

Estimating Everyday Neuropsychological Functioning in Multiple Sclerosis: Reliability and Validity of the Greek Multiple Sclerosis Neuropsychological Questionnaire
por: Konstantinopoulou, Eleni, et al.
Publicado: (2018)

A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination
por: Boziki, Marina, et al.
Publicado: (2021)

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Relationship between Helicobacter pylori infection and multiple sclerosis
por: Gavalas, Emmanuel, et al.
Publicado: (2015)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
por: Boziki, Marina, et al.
Publicado: (2023)

Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment
por: Chatzikonstantinou, Simela, et al.
Publicado: (2021)

Multiple Sclerosis: Shall We Target CD33?
por: Siokas, Vasileios, et al.
Publicado: (2020)

Long-Term Evaluation of Nasal Septoplasty Followed by Inferior Turbinate Cauterization for the Treatment of Nasal Obstruction using Objective and Subjective Methods
por: Valsamidis, Konstantinos, et al.
Publicado: (2018)

Cornelia De Lange Syndrome and Cochlear Implantation
por: Psillas, George, et al.
Publicado: (2018)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis
por: Boziki, Marina, et al.
Publicado: (2022)

Biomarkers in Rare Demyelinating Disease of the Central Nervous System
por: Boziki, Marina, et al.
Publicado: (2020)

Editorial: Complement in nervous system disease
por: Michailidou, Iliana, et al.
Publicado: (2023)

Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial
por: Messinis, Lambros, et al.
Publicado: (2017)

Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options
por: Andravizou, Athina, et al.
Publicado: (2019)

CNS Ageing in Health and Neurodegenerative Disorders
por: Kesidou, Evangelia, et al.
Publicado: (2023)

Virus-mediated autoimmunity in Multiple Sclerosis
por: Grigoriadis, Nikolaos, et al.
Publicado: (2006)

The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases
por: Sintila, Styliani-Aggeliki, et al.
Publicado: (2023)

Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases
por: Gkekas, Ioannis, et al.
Publicado: (2021)

Impact of Body Mass Index on the Age of Relapsing-Remitting Multiple Sclerosis Onset: A Retrospective Study
por: Siokas, Vasileios, et al.
Publicado: (2021)

Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation
por: Mouzaki, Athanasia, et al.
Publicado: (2015)

Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Patient-Reported Outcome Measures in Diseases of the Head and Neck
por: Printza, Athanasia
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_65cuao1j6m955p3gjvho1nas7a